Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen MS Drug Rollout Eyed Ahead Of Q3 Earnings
Biogen MS Drug Rollout Eyed Ahead Of Q3 Earnings
Biogen MS Drug Rollout Eyed Ahead Of Q3 Earnings
Submitted by
admin
on October 26, 2013 - 10:49am
Source:
investors.com
News Tags:
Biogen Idec
MS
multiple sclerosis
Headline:
Biogen MS Drug Rollout Eyed Ahead Of Q3 Earnings
Do Not Allow Advertisers to Use My Personal information
